An assessment of MMP and TIMP gene expression in cell lines and stroma-tumour differences in microdissected breast cancer biopsies

Tumor Biology

Volumn 24, Issue 5, 2003, Pages 258-270

  Mellick, Albert S ^a   Blackmore, Daneia ^a,b   Weinstein, Stephen R ^b   Griffiths, Lyn R ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b GOLD COAST UNIVERSITY HOSPITAL   (Australia)

Author keywords

Fluorescent detection; Formalin fixed paraffin embedded tissues; Infiltrating, ductal carcinoma; Matrix metalloproteinases; Microdissection; Stroma

Indexed keywords

MESSENGER RNA;

ANALYTIC METHOD; ARTICLE; BREAST; BREAST CANCER; CANCER TISSUE; CELL LINE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE; MATRIX METALLOPROTEINASE 11 GENE; MATRIX METALLOPROTEINASE 2 GENE; MATRIX METALLOPROTEINASE 9 GENE; MICRODISSECTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RANK SUM TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA; TISSUE INHIBITOR OF METALLOPROTEINASE 1 GENE; TISSUE INHIBITOR OF METALLOPROTEINASE 2 GENE; TUMOR BIOPSY; TUMOR CALCINOSIS;

EID: 1542373616     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076140     Document Type: Article

References (34)

1. Menck HR, Mills PK: The influence of urbanization, age, ethnicity, and income on the early diagnosis of breast carcinoma: Opportunity for screening improvement. Cancer 2001;92:1299-1304.
2. Anderson TJ, Alexander FE, Lamb J, Smith A, Forrest AP: Pathology characteristics that optimize outcome prediction of a breast screening trial. Br J Cancer 2000;83:487-492.
3. Heimann R, Hellman S: Individual characterisation of the metastatic capacity of human breast carcinoma. Eur J Cancer 2000;36:1631-1639.
4. Clemons M, Danson S, Hamilton T, Goss P: Locoregionally recurrent breast cancer: Incidence, risk factors and survival. Cancer Treat Rev 2001;27:67-82.
5. Perou CM, Sorlie T, Eisen MB, et al: Molecular portraits of human breast tumors. Nature 2000;406:747-752.
6. Simon SL, Parkes A, Leygue E, et al: Expression of a repressor of estrogen receptor activity in human breast tumors: Relationship to some known prognostic markers. Cancer Res 2000;60:2796-2799.
7. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 1991;19:403-410.
8. Thomas PA, Kirschmann DA, Cerhan JR, et al: Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients. Clin Cancer Res 1999;5:698-703.
9. Benaud C, Dickson RB, Thompson EW: Roles of the matrix metalloproteinases in mammary gland development and cancer. Breast Cancer Res Treat 1998;50:97-116.
10. Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161-174.
11. Pacheco MM, Mourao M, Mantovani EB, Nishimoto IN, Brentani MM: Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: Clinico-pathological correlations. Clin Exp Metastasis 1998;16:577-585.
12. Arlt M, Kopitz C, Pennington C, et al: Increase in gelatinase- specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model. Cancer Res 2002;62:5543-5550.
13. Wang Z, Juttermann R, Soloway PD: TIMP-2 is required for efficient activation of proMMP-2 in vivo. J Biol Chem 2000;275:26411-26415.
14. Mott JD, Thomas CL, Rosenbach MT, et al: Post-translational proteolytic processing of procollagen C-terminal proteinase enhancer releases a metalloproteinase inhibitor. J Biol Chem 2000;275:1384-1390.
15. Zucker S, Cao J, Chen WT: Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 2000;19:6642-6650.
16. Hidalgo M, Eckhardt SG: Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst 2001;93:178-193.
17. Yamamoto A, Yano S, Shiraga M, et al: A third-generation matrix metalloproteinase (MMP) inhibitor (ONO-4817) combined with docetaxel suppresses progression of lung micrometastasis of MMP-expressing tumor cells in nude mice. Int J Cancer 2003;103:822-828.
18. Mellick AS, Day CJ, Weinstein SR, Griffiths LR, Morrison NA: Differential gene expression in breast cancer cell lines and stroma-tumor differences in microdissected breast cancer biopsies revealed by display array analysis. Int J Cancer 2002;100:172-180.
19. Ross DT, Scherf U, Eisen MB, et al: Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000;24:227-235.
20. Nicholson GC, Malakellis M, Collier FM, et al: Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor κB ligand (RANKL). Clin Sci (Lond) 2000;99:133-140.
21. Stanta G, Bonin S, Perin R: RNA extraction from formalin-fixed and paraffin-embedded tissues. Methods Mol Biol 1998;86:23-26.
22. Rose'Meyer RB, Mellick AS, Garnham BG, et al: The measurement of adenosine and estrogen receptor expression in rat brains following ovariectomy using quantitative PCR analysis. Brain Res Brain Res Protoc 2003;11:9-18.
23. Thellin O, Zorzi W, Lakaye B, De Borman B, Coumans B, et al: Housekeeping genes as internal standards: Use and limits. J Biotechnol 1999;75:291-295.
24. Foss RD, Guha-Thakurta N, Conran RM, Gutman P: Effects of fixative and fixation time on the extraction and polymerase chain reaction amplification of RNA from paraffin-embedded tissue. Comparison of two housekeeping gene mRNA controls. Diagn Mol Pathol 1994;3:148-155.
25. Lewis F, Maughan NJ, Smith V, Hillan K, Quirke P: Unlocking the archive-gene expression in paraffin-embedded tissue. J Pathol 2001;195:66-71.
26. Yin JL, Shackel NA, Zekry A, et al: Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. Immunol Cell Biol 2001;79:213-221.
27. Bustin SA: Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): Trends and problems. J Mol Endocrinol 2002;29:23-39.
28. Giambernardi TA, Grant GM, Taylor GP, et al: Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol 1998;16:483-496.
29. Singer CF, Kronsteiner N, Marton E, Kubista M, Cullen KJ, et al: MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions. Breast Cancer Res Treat 2002;72:69-77.
30. Morini M, Mottolese M, Ferrari N, et al: The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int J Cancer 2000;87:336-342.
31. Baker EA, Stephenson TJ, Reed MW, Brown NJ: Expression of proteinases and inhibitors in human breast cancer progression and survival. Mol Pathol 2002;55:300-304.
32. Mimori K, Ueo H, Shirasaka C, Mori M: Clinical significance of MT1-MMP mRNA expression in breast cancer. Oncol Rep 2001;8:401-403.
33. James JJ, Evans AJ, Pinder SE, et al: Is the presence of mammographic comedo calcification really a prognostic factor for small screen-detected invasive breast cancers? Clin Radiol 2003;58:54-62.
34. Smith RA, Lea RA, Curran JE, Weinstein SR, Griffiths LR: Expression of glucocorticoid and progesterone nuclear receptor genes in archival breast cancer tissue. Breast Cancer Res 2003;5:R9-R12.